James W. McCollum
Co-Founder & DirectorMr. James W. McCollum, also known as Jim, served as President of LENZ Therapeutics, Inc. and serves as its Director since March 2024. Mr. McCollum co-founded LENZ OpCo and served on LENZ OpCo’s board of directors from July 2013 through the closing of the Merger. From September 2014 to September 2016, Mr. McCollum served as President and Chief Executive Officer of Eye Therapies, LLC. He served as the Chief Executive Officer and President of Restoration Robotics, Inc. Mr. McCollum is the Co-founder, President and Director of Presbyopia Therapies, LLC. Mr. McCollum joined Restoration Robotics in October 2005, Mr. McCollum served as the President and Chief Executive Officer of Vision Membrane Technologies (VMT), an ophthalmic surgical device company with revolutionary intraocular lens (IOL) technology for refractive indications. Prior to VMT, Mr. McCollum served as the President and Chief Executive Officer of Argus Biomedical, the first company to commercialize an artificial cornea. He successfully negotiated the sale of Argus to CooperVision Surgical in early 2004. Earlier, he served as Vice President of Worldwide Marketing and Sales at VISX, playing a key leadership role in helping create a new market category: LASIK eye surgery. Prior to VISX, Mr. McCollum served as the General Manager for CooperVision (Contact Lens Division). He served as a Director of Restoration Robotics, Inc. Mr. McCollum received a B.A. in Business from North Carolina State University.
Positions
- Company NameLENZ Therapeutics, Inc.Stock CodeLENZPositionCo-Founder & DirectorColleagues
- EBEvert B. SchimmelpenninkPresident, CEO, Secretary & Director
- JPJeffrey P. GeorgeIndependent Chairman
- SOShawn OlssonChief Commercial Officer
- MGMarc G. OdrichChief Medical Officer
- DRDaniel R. ChevallardCFO, Principal Financial & Accounting Officer
- FGFrederic GuerardIndependent Director
- SBShelley B. ThunenIndependent Director
